Polen Capital Management
AKTS

Polen Capital Management’s Aktis Oncology AKTS Stock Holding History

Polen Capital Management’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.05M Buy
+63,514
New +$1.3M 0.02% 125

Other funds holding AKTS

TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Polen Capital Management's AKTS Position: Q2 2026 in Review

Polen Capital Management opened a new position in Aktis Oncology (AKTS) in Q2 2026: 63,514 shares worth $2.05M. The stake represents 0.02% of the portfolio and ranks #125 among its holdings.

21 funds tracked by Wall St. Rank hold AKTS as of Q2 2026.

  • Polen Capital Management held 63,514 shares of Aktis Oncology worth $2.05M as of Q2 2026.
  • Aktis Oncology was a new Polen Capital Management position in Q2 2026.
  • Aktis Oncology made up 0.02% of Polen Capital Management's portfolio in Q2 2026, its #125 holding.
  • 21 funds tracked by Wall St. Rank held Aktis Oncology as of Q2 2026.

Based on Polen Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.